Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 Aug;145(2):490–497.

Retinal and choroidal neovascularization in a transgenic mouse model of sickle cell disease.

G A Lutty 1, D S McLeod 1, A Pachnis 1, F Costantini 1, M E Fabry 1, R L Nagel 1
PMCID: PMC1887388  PMID: 7519831

Abstract

A complication of sickle cell disease is proliferative retinopathy. We investigated the eyes from a transgenic mouse model of sickle cell disease (alpha H beta S[beta MDD] type) to determine if pathological changes occurred in their retinas and choroids. One retina from each animal was processed by flat-embedding adenosine diphosphatase-reacted retinas in glycol methacrylate. The fellow eye from each animal was embedded whole in glycol methacrylate for histopathological analysis of all ocular structures. Retinal vascular occlusions resulted in nonperfused areas of retina and arterio-venous anastomoses. Intra- and extraretinal neovascularization was observed adjacent to nonperfused areas. Retinal pigmented lesions were formed by the migration of retinal pigment epithelial cells into sensory retina, often ensheathing choroidal neovascularization. The incidence of this bilateral chorioretinopathy was 30% in animals older than 15 months of age. The ocular histopathological changes we observed in the mouse model mimicked many aspects of human proliferative sickle cell retinopathy. Furthermore, this is the first genetically derived animal model for chorio-retinal neovascularization.

Full text

PDF
490

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fabry M. E., Costantini F., Pachnis A., Suzuka S. M., Bank N., Aynedjian H. S., Factor S. M., Nagel R. L. High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12155–12159. doi: 10.1073/pnas.89.24.12155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fabry M. E., Nagel R. L., Pachnis A., Suzuka S. M., Costantini F. High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12150–12154. doi: 10.1073/pnas.89.24.12150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Foulds W. S., Lee W. R., Taylor W. O. Clinical and pathological aspects of choroidal ischaemia. Trans Ophthalmol Soc U K. 1971;91:323–341. [PubMed] [Google Scholar]
  4. Goldberg M. F. Retinal vaso-occlusion in sickling hemoglobinopathies. Birth Defects Orig Artic Ser. 1976;12(3):475–515. [PubMed] [Google Scholar]
  5. Kaul D. K., Fabry M. E., Nagel R. L. Erythrocytic and vascular factors influencing the microcirculatory behavior of blood in sickle cell anemia. Ann N Y Acad Sci. 1989;565:316–326. doi: 10.1111/j.1749-6632.1989.tb24179.x. [DOI] [PubMed] [Google Scholar]
  6. LaVail M. M. Analysis of neurological mutants with inherited retinal degeneration. Friedenwald lecture. Invest Ophthalmol Vis Sci. 1981 Nov;21(5):638–657. [PubMed] [Google Scholar]
  7. Lutty G. A., McLeod D. S. A new technique for visualization of the human retinal vasculature. Arch Ophthalmol. 1992 Feb;110(2):267–276. doi: 10.1001/archopht.1992.01080140123039. [DOI] [PubMed] [Google Scholar]
  8. Lutty G. A., Merges C., Crone S., McLeod D. S. Immunohistochemical insights into sickle cell retinopathy. Curr Eye Res. 1994 Feb;13(2):125–138. doi: 10.3109/02713689409042407. [DOI] [PubMed] [Google Scholar]
  9. McLeod D. S., Goldberg M. F., Lutty G. A. Dual-perspective analysis of vascular formations in sickle cell retinopathy. Arch Ophthalmol. 1993 Sep;111(9):1234–1245. doi: 10.1001/archopht.1993.01090090086026. [DOI] [PubMed] [Google Scholar]
  10. Ryan T. M., Townes T. M., Reilly M. P., Asakura T., Palmiter R. D., Brinster R. L., Behringer R. R. Human sickle hemoglobin in transgenic mice. Science. 1990 Feb 2;247(4942):566–568. doi: 10.1126/science.2154033. [DOI] [PubMed] [Google Scholar]
  11. Skow L. C., Burkhart B. A., Johnson F. M., Popp R. A., Popp D. M., Goldberg S. Z., Anderson W. F., Barnett L. B., Lewis S. E. A mouse model for beta-thalassemia. Cell. 1983 Oct;34(3):1043–1052. doi: 10.1016/0092-8674(83)90562-7. [DOI] [PubMed] [Google Scholar]
  12. Trudel M., Saadane N., Garel M. C., Bardakdjian-Michau J., Blouquit Y., Guerquin-Kern J. L., Rouyer-Fessard P., Vidaud D., Pachnis A., Roméo P. H. Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD. EMBO J. 1991 Nov;10(11):3157–3165. doi: 10.1002/j.1460-2075.1991.tb04877.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wobmann P. R., Fine B. S. The clump cells of Koganei. A light and electron microscopic study. Am J Ophthalmol. 1972 Jan;73(1):90–101. doi: 10.1016/0002-9394(72)90311-x. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES